Search
AVN-944
go.drugbank.com/drugs/DB05500InvestigationalAVN944 is a biotech drug that demonstrated a statistically meaningful impact on IMPDH and other proteins that are critical to activities in cancer cells, including nucleotide biosynthesis, energy and metabolism … AVN944 has been associated with cancer cell death in clinical trials. It is being investigated for the treatment of patients with advanced hematologic malignancies.
ATP
go.drugbank.com/drugs/DB00171InvestigationalNutraceuticalAn adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
Vespula maculifrons venom protein
go.drugbank.com/drugs/DB10956ApprovedVespula maculifrons venom protein is an extract of Vespula maculifrons venom. Vespula maculifrons venom protein is used in allergenic testing.
Dolichovespula maculata venom protein
go.drugbank.com/drugs/DB10958ApprovedDolichovespula maculata venom protein is an extract of Dolichovespula maculata venom. Dolichovespula maculata venom protein is used in allergenic testing.
Polistes annularis venom protein
go.drugbank.com/drugs/DB11027ApprovedPolistes annularis venom protein is an extract of Polistes annularis venom. Polistes annularis venom protein is used in allergenic testing.
Vespula germanica venom protein
go.drugbank.com/drugs/DB11030ApprovedVespula germanica venom protein is an extract of Vespula germanica venom. Vespula germanica venom protein is used in allergenic testing.
Pimagedine
go.drugbank.com/drugs/DB05383InvestigationalIt is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. … Pimagedine has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease.
Nitroaspirin
go.drugbank.com/drugs/DB12445InvestigationalNitroaspirin has been investigated for the treatment of Intermittent Claudication.
Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSHuman Umbilical Cord Mesenchymal Stem Cells
go.drugbank.com/drugs/DB15726Investigationaldoubling time (DT) over up to 10 passages), higher differentiation capability, and faster self-renewal. … The explant method requires manual mincing of the tissue fragments and results in an inconsistent number of extracted MSCs.
Emricasan
go.drugbank.com/drugs/DB05408InvestigationalEmricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. … It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.